glp 1 or glp 2 Discovery, characterization, and clinical development of the glucagon-like peptides GLP-1 receptor agonists | How

E., Spiegelman, D., Barbieri, R

The GLP-1RAs are achieving blockbuster status, meaning a drug that generates yearly sales exceeding one billion dollars for a drug company

Heres what to actually eat, the best fat and protein swaps, and the high-carb or hidden-dairy foods to avoid

Lilly is expecting another revenue rise of around 32% in 2025, and analysts are expecting it to grow its share of the GLP-1 market across diabetes and obesity (it ended 2024 with 34% compared with Novo Nordisks 63%)

Hypothyroidism: A sluggish thyroid can impede stomach emptying

Standard dosing is evidence-based, while microdosing, using lower-than-prescribed doses, has gained attention despite limited evidence, with potential benefits offset by concerns about reduced efficacy, safety risks, and lack of clinical validation